Crohns Disease Diagnostics And Therapeutic Market Share 2030
Crohns Disease Diagnostics And Therapeutic Market Share 2030
Segments - Crohns Disease Diagnostics and Therapeutics Market by Diagnostics (Fecal Test, Blood Test, Colonoscopy, Computerized Tomography, Flexible Sigmoidoscopy, Magnetic Resonance Imaging, Other Diagnostic Tests (Capsule, Endoscopy, etc.)), Treatment (Medication [Immunosuppressant, Anti-inflammatory Agents, Analgesics and Antipyretics, and Others] and Surgery), Regions (North America, Europe, Asia Pacific, Middle East & Africa, and South America)- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
Upcoming
| Report ID :HC-3755
| 4.7 Rating
| 76 Reviews
| 214 Pages
| Format :
Report Description
The global crohn disease diagnostics and therapeutics market size is expected to expand at a significant CAGR during the forecast period, 2021-2028. The growth of market is attributed to growing awareness of crohn’s diseases, along with initiatives by legal authorities within the region for the development of novel treatment.
Crohn’s diseases (CD) are an inflammatory bowel disease (IBD) that affects the part of gastrointestinal tract, anywhere from mouth to anus.
According to the crohn’s and colitis foundation (CCFA), approximately 70,000 new cases of crohn are diagnosed in U.S. almost every year, as per the 2019 report of CCFA around 1.4 million people were suffering from inflammatory bowel diseases.
With the sudden emergency of COVID-19 global economy faced a massive downfall in the industry; due to complete lockdown protocol implemented by the government of the countries and restricted the movements a major downfall in inflammatory bowel diseases has been observed globally.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing adoption of biologics for effective treatment is estimated to boost the market during the projected period.
- Increased presences of strong drugs for the disease such as upadacitinib, tofacitnib, and more is anticipated propel the market in the coming years.
- Growing awareness about the disease and initiatives by government bodies for the development of novel treatment options is expected to spur the market during the forecast period.
- High cost of treatment process acts as one of the factor that can hinder the growth of the market in the coming years.
- Lack of awareness about the disease possesses a challenge that can hamper the market during the projected period.
Scope of the market
The report on the global crohns disease diagnostics and therapeutic market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Crohns Disease Diagnostics And Therapeutic Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Diagnostics (Fecal Test, Blood Test, Colonoscopy, Computerized Tomography, Flexible Sigmoidoscopy, Magnetic Resonance Imaging, Other Diagnostic Tests (Capsule, Endoscopy, etc.)), Treatment (Medication [Immunosuppressant, Anti-inflammatory Agents, Analgesics and Antipyretics, and Others] and Surgery) |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South America |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | GeneTech; Celgene Corporation; Janssen Biotech Inc.; Abbvie Inc.; Pfizer Inc. |
Market Segment Insights
The colonoscopy segment is expected to exhibit high CAGR
Based on the diagnostics, the market is segregated into fecal test, blood test, colonoscopy, computerized tomography, flexible sigmoidoscopy, magnetic resonance imaging, and other diagnostic tests (capsule, endoscopy, etc.). The colonoscopy segment is expected to exhibit high CAGR in the coming years due to the involvement of less invasive procedure to essentially and accurately confirm the disease of crohn is estimated to spike the market.
The anti-inflammatory agents segment is estimated to hold key share of the market
On the basis of treatment, the market is categorized into medication, and surgery. The medication segment is further segregated into immunosuppressant, anti-inflammatory agents, analgesics and antipyretics, and others. The anti-inflammatory agents segment is estimated to hold key share of the market in the coming years due to reduced surgeries and hospitalization rates, along with their high efficiency as compared to immunosuppressant and analgesic.
North America is anticipated to dominate the market
In terms of regions, the market is classified as North America, Europe, Asia Pacific, Middle East and Africa, and South America. North America is anticipated to dominate the market during the forecast period owing to increasing number of people suffering from crohn diseases within the region, also attributed to the increasing urbanization and changing lifestyle, diet, smoking habits, industrial chemical emission, pollution, and difference in exposure of sunlight contributes in escalation of the segment.
Segments
Crohn disease diagnostics and therapeutics market has been segmented on the basis ofDiagnostics
- Fecal Test
- Blood Test
- Colonoscopy
- Computerized Tomography
- Flexible Sigmoidoscopy
- Magnetic Resonance Imaging
- Other Diagnostic Tests (Capsule, Endoscopy, etc.)
- Medication
- Immunosuppressant
- Anti-inflammatory Agents
- Analgesics and Antipyretics
- Others
- Surgery
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
- GeneTech
- Celgene Corporation
- Janssen Biotech Inc.
- Abbvie Inc.
- Pfizer Inc.
Competitive Landscape
Key players competing in the Crohn disease diagnostics and therapeutics market include GeneTech; Celgene Corporation; Janssen Biotech Inc.; Abbvie Inc.; Pfizer Inc.
Some of these players are targeting on business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Crohns Disease Diagnostics And Therapeutic Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Crohns Disease Diagnostics And Therapeutic Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Crohns Disease Diagnostics And Therapeutic Market - Supply Chain
4.5. Global Crohns Disease Diagnostics And Therapeutic Market Forecast
4.5.1. Crohns Disease Diagnostics And Therapeutic Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Crohns Disease Diagnostics And Therapeutic Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Crohns Disease Diagnostics And Therapeutic Market Absolute $ Opportunity
5. Global Crohns Disease Diagnostics And Therapeutic Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Crohns Disease Diagnostics And Therapeutic Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Crohns Disease Diagnostics And Therapeutic Demand Share Forecast, 2019-2026
6. North America Crohns Disease Diagnostics And Therapeutic Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Crohns Disease Diagnostics And Therapeutic Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Crohns Disease Diagnostics And Therapeutic Demand Share Forecast, 2019-2026
7. Latin America Crohns Disease Diagnostics And Therapeutic Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Crohns Disease Diagnostics And Therapeutic Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Crohns Disease Diagnostics And Therapeutic Demand Share Forecast, 2019-2026
8. Europe Crohns Disease Diagnostics And Therapeutic Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Crohns Disease Diagnostics And Therapeutic Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Crohns Disease Diagnostics And Therapeutic Demand Share Forecast, 2019-2026
9. Asia Pacific Crohns Disease Diagnostics And Therapeutic Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Crohns Disease Diagnostics And Therapeutic Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Crohns Disease Diagnostics And Therapeutic Demand Share Forecast, 2019-2026
10. Middle East & Africa Crohns Disease Diagnostics And Therapeutic Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Crohns Disease Diagnostics And Therapeutic Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Crohns Disease Diagnostics And Therapeutic Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Crohns Disease Diagnostics And Therapeutic Market: Market Share Analysis
11.2. Crohns Disease Diagnostics And Therapeutic Distributors and Customers
11.3. Crohns Disease Diagnostics And Therapeutic Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. GeneTech
11.4.2. Celgene Corporation
11.4.3. Janssen Biotech Inc.
11.4.4. Abbvie Inc.
11.4.5. Pfizer Inc.
Methodology
Related Reports
Some other reports from this category!
Our Clients
